#microbiome sequencing

[cleareaglecloud]

Microbiome Sequencing Services Market Size, Share, Trends and Revenue Forecast, 2028 | MarketsandMarkets

The global microbiome sequencing services market in terms of revenue was estimated to be worth $284 million in 2023 and is poised to reach $

[gvr-research]

Microbiome Sequencing Services Market To Reach $3.10Bn By 2030

Microbiome Sequencing Services Market Growth & Trends

The global microbiome sequencing services market size is projected to reach USD 3.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.9% from 2023 to 2030, as a result of rising investment and an increase in genomic research globally. For instance, in October 2022, Danish microbiome research comp1any, Clinical Microbiomics announced that venture capital firm Seventure Partners had invested €10 million ($9.7 million) in the company. The funds will be used by Clinical Microbiomics to advance the systems biology and microbiome profiling platforms, as well as to broaden the scope of their service offerings for multi-omics data integration and extend their reach internationally, starting with the US. Due to a large number of genomic initiatives for research and development, the market for microbiome sequencing services is growing.

With growing evidence that microbiomes have a significant effect on human health, the research on microbiome sequencing has advanced considerably in recent years. Studies investigating the variety of microbes that exist on and inside human bodies are now possible easily since there have been major improvements in sequencing technologies and significant declines in the costs of services. Furthermore, growing research on how the human body's microbiome influences certain aspects of human physiology provides enormous potential for the development of novel treatments and preventative measures for a wide range of diseases including cancer, mental health disorders, autoimmune conditions, and infectious diseases. This growing research on the microbiome is expected to drive the demand for microbiome sequencing services.

The COVID-19 pandemic has had positive effects on the market for microbiome sequencing services. Microbiome sequencing is mainly employed in the fields of infectious disease and cancer. The existence of the virus and the host's reaction to COVID-19 may be determined through RNA sequencing. Therefore, one of the key factors supporting its development in 2020 and beyond was the increasing adoption of microbiome sequencing tools during the COVID-19 pandemic.

Moreover,the government's partnerships with industry participants for extensive virus research also fueled the pandemic's high demand for microbiome sequencing. For instance, the UK established a genome sequencing partnership in March 2020 to facilitate rapid, comprehensive, and exhaustive sequencing analysis of samples from patients who tested positive for COVID-19. The network seeks to sequence every positive patient sample for the virus. Oxford Nanopore is pleased to assist the teams working on this initiative in the UK

Request a free sample copy or view report summary: Microbiome Sequencing Services Market Report

Microbiome Sequencing Services Market Report Highlights

The sequencing by synthesis segment held the largest share of 57.5% in 2022 and is expected to expand at a lucrative CAGR during the forecast period. This is a result of the sequencing by synthesis method's highly parallel nature, which enables the simultaneous sequencing of millions of amplicons, which has greatly increased interest in the study of bacterial communities

By application, the gastrointestinal disorders segment accounted for the largest share of 54.0% in the market in 2022. This can be attributed to the high incidences of gastrointestinal disorders and growing awareness related to the gut microflora and the use of probiotics

By end-user, the academic research institutes segment held the largest share of 43.3% in 2022. The widespread application of microbiome sequencing services for protein, as well as small molecule analysis in research institutions and academics, contributes to the segment's high market share

North America held the largest market share of 47.85% in 2022. The high regional market share is largely due to the rise in the usage of extremely sophisticated techniques and systems in microbiome sequencing services and the technological developments made in genomic research studies. Furthermore, the market in North America is expected to develop more rapidly due to the increase in the adoption of technologically advanced methods and platforms in the microbiome sequencing services and advances in technology made in genomic research studies

Microbiome Sequencing Services Market Segmentation

Grand View Research has segmented the global microbiome sequencing services market based on technology, application, end-user, and region:

Microbiome Sequencing Services Technology Outlook (Revenue, USD Million, 2018 - 2030)

Sequencing By Synthesis

Sequencing By Ligation

Sanger Sequencing

Others

Microbiome Sequencing Services Application Outlook (Revenue, USD Million, 2018 - 2030)

Autoimmune Disorder

Cancer

Gastrointestinal Disorders

Others

Microbiome Sequencing Services End-User Outlook (Revenue, USD Million, 2018 - 2030)

Pharmaceutical & Biotechnology Companies

Academic Research Institutes

Others

Microbiome Sequencing Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in the Microbiome Sequencing Services Market

Microbiome Insights Inc.

Baseclear BV

Clinical-Microbiomics A/S

Mérieux NutriSciences Corporation

MR DNA

Metabiomics Corp.

Rancho BioSciences

Second Genome

Zymo Research Corporation

uBiome, Inc.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: [phone]

Toll Free: 1-888-202-9519

Email: [email protected]

Web: https://www.grandviewresearch.com

Grand View Compass | Astra ESG Solutions

Follow Us: LinkedIn | Twitter

[eurofinsindia]

Enter a new dimension of Skincare: Microbiome

“Skin is the largest organ of our body, and every individual’s skin is fundamentally different. Skin is protected by many micro-organism, to

[researchupdates]

Future Scope of Microbiome Sequencing Market | Estimated to Grow CAGR Rapidly | Foreseen till 2028

Global Microbiome Sequencing Market Synopsis:

The exclusive research report on the Global Microbiome Sequencing Market 2021-2028 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Microbiome Sequencing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

The Global Microbiome Sequencing Market to account USD 4.71 Billion by 2028 growing at a CAGR of 18.7% in the forecast period of 2021-2028.

Available Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-microbiome-sequencing-market .

According to the market report analysis, Microbiome Sequencing is defined as a research technology which includes the study of microbes and their roles in the maintenance of healthcare as well as prevalence of diseases. This is mainly carried out by sampling out the human blood, stool and skin. These samples are used for tests that are tried in the labor-intensive techniques of microbiology studies wherein they can isolate the organisms in these samples through the help of genotypic or phenotypic analysis.

The major key factors driving the growth of the Global Microbiome Sequencing Market are increase in the adoption of genomic research methods coupled with the widening areas of application for microbiome sequencing technology. Additionally, growing demand for next generation services, low cost related with the NGS technology which will also increase the adoption rate are the driving factors accelerating the growth of the Microbiome Sequencing Market.

The major players covered in the Microbiome Sequencing Market report are CosmosID, Charles River Laboratories, Diversigen, BIOLOG, Illumina, Inc., Metabiomics Corp., Oxford Nanopore Technologies, BaseClear B.V., BGI, BioMathematica, Microbiome Therapeutics Innovation Group, Clinical-Microbiomics A/S, Eurofins Scientific, LABCYTE INC., Leucine Rich Bio Pvt Ltd., Microbiome Insights, Zymo Research Corporation, Thermo Fisher Scientific Inc., Molzym GmbH & Co. KG, Norgen Biotek Corp., Phase Genomics Inc., QIAGEN, Resphera Biosciences, LLC, Shoreline Biome, StarSEQ GmbH, Viome, Inc, among other domestic and global players.

Regionally, North America dominates the microbiome sequencing market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to increase in the research activities related to genomics, rising number of research studies on cancer and inherited rare disorders and growing government support in this region. Asia-Pacific

Access Complete Report @ https://www.databridgemarketresearch.com/reports/global-microbiome-sequencing-market .

[retrogeninc]

What is Next Generation Sequencing

Next generation or NGS sequencing is considered to be an important technology for the determination of the RNA or DNA sequence. So, this technology of NGS sequencing is mainly used for studying variation that is linked with several biological phenomena or disease.

This was introduced in the year 2005 for commercial use. Previously, this particular method was known as the massively-parallel sequencing. The NGS sequencing was known so because it contributes to enabling the sequencing of several DNA strands all at the same time.

Nowadays, these technologies are mostly used in the genetic analysis environment. In this aspect, Sanger sequencing is best for analyzing the small number of samples and gene targets.

Not only that, but this is regarded as the gold standard sequencing technology. So, the results of NGS sequencing are mainly verified by using the Sanger sequencing. Also, the NGS enables the interrogation of multiple genes present in various samples all at one time.

It also involves the analysis and discovery of diverse types of genomic features in a single sequencing run.

Therefore, the NGS sequencing contributes to providing the ideal throughput per run and with the help of this particular technology, studies can be conducted cost-effectively and quickly.

Some other benefits that are associated with the NGS are higher accuracy, lower sample input requirements, etc. Along with that, this technique particularly can detect variants at lower allele frequencies when compared to the Sanger sequencing.

As a result, the throughput, speed, and accuracy of NGS have hugely revolutionized genetic analysis. Also, it contributes to enabling new applications in forensic, agricultural, environmental science, reproductive health, and clinical and genomic research.

Important Advantages Of NGS

NGS can be particularly used for proper analysis of RNA and DNA samples. This is a well-known tool in functional genomics. Below are mentioned some of the most important advantages of NGS such as:

For performing this procedure, any specialized knowledge about the genomic features or genome is not needed.

This technology contributes to offer single-nucleotide resolution and thereby, making it possible to properly detect related genes. Not only that, but it also helps in the detection of single nucleotide polymorphisms, allelic gene variants, alternatively spliced transcripts, etc.

It generally shows a higher dynamic range of the signal.

Not only that, but it effectively shows higher reproducibility.

It requires less RNA or DNA as inputs. So, in this case, the nanograms of the materials are considered to be sufficient.

Final Words

So, it is evident from the above section, that NGS sequencing has become an important technology in the current days. This is also known as high-throughput sequencing.

When compared to the Sanger sequencing, this particular technology allows for the sequencing of RNA and DNA much more quickly and also at an affordable rate.

In this way, this specific technology has revolutionized the study of molecular biology and genomics. But, as the procedure is highly complex and so, it should be performed by bioinformatics specialists.

[norahtrent61-blog]

global Microbiome Sequencing Services market, analyzes and researches the Microbiome Sequencing Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia